Here are relevant reports on : congenital-heart-disease-treatment-devices-market
-
Medical Bionic Implant /Artificial Organs Market - (Vision Bionics/Bionic Eye, Brain Bionics, Heart Bionics/Artificial Heart, Orthopedic Bionics and Ear Bionics) – Trends and Global Forecasts to 2017
Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implants market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.
- Published: November 2012
- Price: $ 4950
- TOC Available:
-
Parkinson's Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) - Global Forecast to 2022
The Parkinson's disease treatment market is expected to reach USD 5.69 Billion by 2022 from USD 4.24 Billion in 2017, at a CAGR of 6.1%. The market is being driven by the growth in aging population and the associated increase in the prevalence of Parkinson’s disease and government funding for research. Some of the major players operating in the Parkinson’s disease treatment market include Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), Boehringer Ingelheim (Germany), Impax Laboratories (US), Lundbeck (Denmark), Sun Pharma (India), Wockhardt (India), UCB (Belgium), Valeant Pharmaceuticals (Canada), and Acadia (US).
- Published: October 2017
- Price: $ 4950
- TOC Available:
-
Cardiac Surgery Instruments Market by Product (Clamps, Forceps, Scalpel, Scissors, Needle Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery, Pediatric Surgery, Heart Transplant), & End User (Hospital, ASC) - Global Forecast to 2022
The cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017, at a CAGR of 7.1%. The market is mainly driven by factors such as high incidence of cardiac diseases, growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Overactive Bladder Treatment Market Size by Drug type (Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) & Region - Global Forecast to 2027
The size of global overactive bladder treatment market in terms of revenue was estimated to be worth USD 3.5 billion in 2022 and is poised to reach USD 4.2 billion by 2027, growing at a CAGR of 3.6% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2022
- Price: $ 7150
- TOC Available:
-
Endoluminal Suturing Devices Market Size, Growth by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecasts to 2027
The global endoluminal suturing devices market in terms of revenue was estimated to be worth $78 million in 2022 and is poised to reach $139 million by 2027, growing at a CAGR of 12.0% from 2022 to 2027. The prominent players in this market are Apollo Endosurgery, Inc. (US), Johnson & Johnson (US), Medtronic Plc (Ireland), Cook Group Incorporated (US), USGI Medical (US), Ovesco Endoscopy AG (Germany), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (US), and Sutrue Ltd. (UK).
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer ) and Diagnosis Type (Syndromic, Aetiological, Prognosis) - Global Forecast to 2030
Global respiratory diagnostics market valued at $5.84B in 2024, reached $6.17B in 2025, and is projected to grow at a robust 6.5% CAGR, hitting $9.02B by 2030. The major factors driving the growth of this market include the rising incidence of respiratory disorders, the expanding geriatric population and the rise in sedentary lifestyles, growing awareness about respiratory health, and advancements in diagnostic technologies.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Neurovascular Devices Market by Disease Pathology (Cerebral Aneurysm (Embolic coils, Flow Diverters), Ischemic Stroke (Clot Retriever, Aspiration, Snare), Carotid Stenosis (Stent, Embolic Protection), Others), End User (Hospitals) - Global Forecast to 2030
The global neurovascular devices market, valued at US$4.27 billion in 2024, stood at US$4.64 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2024 to 2030, culminating in a forecasted valuation of US$7.22 billion by the end of the period. The market growth is primarily driven by the prevalence of neurovascular diseases, influenced by factors such as aging populations, hypertension, smoking, and sedentary lifestyles.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Produced Water Treatment Market by Application (Onshore, Offshore), Source (Conventional, Unconventional), Treatment (Primary treatment, Secondary treatment, Tertiary treatment) and Region - Global Forecast to 2029
The produced water treatment market is projected to reach USD 13.4 billion by 2029, at a CAGR of 4.7% during the forecast period. Some of the major players in the produced water treatment market are SLB (US), Baker Hughes Company (US), Siemens Energy (Germany), Veolia Environnement SA (France), TechnipFMC (UK). The major strategies adopted by these players include sales contracts, product launches, investments, collaborations, partnerships, and expansions.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Emission Regulations By Vehicle Type (Off-Highway, On-Highway, Marine & Locomotive), After Treatment Devices (DPF, Doc, SCR, LNT), Engine Technologies (GDI, Twin Turbo, Others) & Region – Global Outlook & Technology Impact Analysis to 2026
Growing concerns towards increasing limits of vehicular emissions, and consequently causing health & environment hazards has led to increased stringency of emission and fuel efficiency regulations. The study discusses about the evolution of emission norms across the key regions & countries and the future of these regulations to 2025.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
